Inovio Pharma (INO) Commences INO-3112 Phase I/IIa
Tweet Send to a Friend
Inovio Pharma (AMEX: INO) has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE